Home
CLYM vs SEER Comparison

CLYM vs SEER Comparison

Compare CLYM & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLYM

SEER

Machine Learning Prediction

ML Decision
CLYM
SEER

Stock Information

Founded
CLYM 2018
SEER 2017

Country
CLYM United States
SEER United States

Employees
CLYM N/A
SEER N/A

Industry
CLYM
SEER Medicinal Chemicals and Botanical Products

Sector
CLYM
SEER Health Care

Exchange
CLYM NYSE
SEER Nasdaq

Market Cap
CLYM 101.6M
SEER N/A

IPO Year
CLYM 2021
SEER 2020

Fundamental

Price
CLYM $1.28
SEER $1.74

Analyst Decision
CLYM
SEER Hold

Analyst Count
CLYM 0
SEER 1

Target Price
CLYM N/A
SEER $3.00

AVG Volume (30 Days)
CLYM 181.1K
SEER 234.2K

Earning Date
CLYM 03-25-2025
SEER 05-07-2025

Dividend Yield
CLYM N/A
SEER N/A

EPS Growth
CLYM N/A
SEER N/A

EPS
CLYM N/A
SEER N/A

Revenue
CLYM N/A
SEER $14,170,000.00

Revenue This Year
CLYM N/A
SEER $29.77

Revenue Next Year
CLYM N/A
SEER $47.98

P/E Ratio
CLYM N/A
SEER N/A

Revenue Growth
CLYM N/A
SEER N/A

52 Week Low
CLYM $1.20
SEER $1.56

52 Week High
CLYM $11.55
SEER $2.63

Technical

Relative Strength Index (RSI)
CLYM N/A
SEER 21.38

Support Level
CLYM N/A
SEER $1.78

Resistance Level
CLYM N/A
SEER $1.86

Average True Range (ATR)
CLYM 0.00
SEER 0.07

MACD
CLYM 0.00
SEER -0.01

Stochastic Oscillator
CLYM 0.00
SEER 1.64

About CLYM CLIMB BIO INC

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

Share on Social Networks: